LSD acts as a potent 5-HT2A receptor agonist, modulating serotonergic neurotransmission and potentially disrupting aberrant neural network connectivity associated with Visual Snow Syndrome. Its hallucinogenic properties and neuroplastic effects may help reset cortical hyperexcitability and reduce sensory processing abnormalities, though its therapeutic use remains experimental and requires further clinical investigation.